Gairing SJ, Mangini C, Zarantonello L, et al
Your body pays an energy tax before you see any benefit the liver has to process alcohol precursors and burn ATP just to unlock the fuel
Effect of statins on toll-like receptors: a new insight to pleiotropic effects
Weighing the potential savings from reducing comorbidity against the competitive landscape of GLP1 drugs, the combination of lower upfront costs and improved wellness could contribute to broader acceptance of GLP1 use by health plans and policymakers
On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established Green List.[1] This action follows FDAs September 5 th announcement of the Green List initiative to curb illegal imports of semaglutide, tirzepatide, and other corresponding APIs.[2] Together, the Green List and Import Alert form FDAs most aggressive enforcement measures to date against GLP-1 imports
By supporting your gut, youre helping your entire system stay calmer and more resilient